Clinical trials
Recruiting Lymphoma, T-Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Beijing GoBroad Hospital | 2 |
| Dizal Pharmaceuticals | 1 |
| Essen Biotech | 1 |
| Fudan University | 1 |
| Peking University People's Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 11 |
| Lymphoma, T-Cell, Cutaneous | 3 |
| Leukemia, Large Granular Lymphocytic | 2 |
| Lymphoma, T-Cell, Peripheral | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Leukemia, Myeloid, Acute | 1 |
| Leukemia, Prolymphocytic, T-Cell | 1 |
| Leukemia, T-Cell | 1 |
| Mycosis Fungoides | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.